NCT03260855View on ClinicalTrials.gov

Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

February 2, 2021

Study Completion Date

March 2, 2023

Conditions
Lymphoma
Interventions
OTHER

Questionnaires/Scales

Scale of Fear of Cancer Recurrence Inventory, Hospital Anxiety and Depression Scale, Evaluation of stress and life quality.

OTHER

Human blood sample

The intervention is based on blood test.

Trial Locations (1)

31000

Institut Universitaire du Cancer de Toulouse CHU de Toulouse, Toulouse

All Listed Sponsors
collaborator

Fondation de l'Avenir

OTHER

lead

University Hospital, Toulouse

OTHER

NCT03260855 - Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship | Biotech Hunter | Biotech Hunter